FDA
approval
· 2013-10-10
FDA Approved: KRYSTEXXA — Supplemental Application (Horizon Therapeutics USA, Inc.)
Summary
FDA approved a supplemental Biologics License Application for Krystexxa (pegloticase) submitted by Horizon Therapeutics USA, Inc. The action confirms regulatory…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for KRYSTEXXA (PEGLOTICASE)